Pharmaceutical Commerce - June 2018 - 15

F E AT U R E

However, there is a much bigger goal that we are after.
the pharma industry doesn't have to worry about divided
Even today, pharma supply chains are insecure, prone to
attention from us. But it's interesting to realize that supply
creating waste, and highly inefficient. It's ridiculous, in
chains in these two industries have many similarities. Food
my opinion, to see what the industry goes through for a
starts with agriculture and minerals, and pharma APIs
product recall, because they cannot track their products
start with many of the same suppliers. On the consumer
all the way through the supply chain. People die from
side, there are many of the same customers-Walmart,
counterfeit drugs because the supply chain security is
for example, sells food and sells pharmaceuticals. The
weak. The last-mile problem in today's supply chains is a
only divergence is in the middle with manufacturing
nightmare, destroying much of the value of all the work
and processing. Optel's goal is a data-driven, optimized,
being done on traceability on the
intelligent supply chain, and that
manufacturing side.
is only possible when the supply
For the past two years, I
chain network is fully integrated.
Our goal is to optimize the
took a step back to look at our
supply chain, and with a
business, which is currently
Finally, Optel has made
connection
direct
to
the
a substantial effort in the
about establishing compliance
direction of sustainability
with the national laws around
consumer. No one on the market
and social responsibility.
the world. That's important, but
is doing that now; everyone
O ptel is one of the few
it is only a part of the solution.
companies in the pharma
Even in Europe with the FMD
is focused on compliance and
traceability arena that
regulations, it's just an aspect
brand protection.
is a designated "B"
of the supply chain; it doesn't
corporation. Why is this
extend to the patient. Overall,
important to Optel, and-
in the context of how Optel can
more importantly-what does it mean for
create positive impact on society, we have a vision that
Optel customers?
we need to connect to people. In the next 10 years, we
will see a convergence of supply chains, running from raw
As I've said, our focus on social good has been there
materials, through manufacturing and production, and on
since
the beginning. Today, there's a trend: we've started
to the consumer.
noticing
that competitors are using the same language as
Our goal is to optimize the supply chain, and with a
we
do
to
talk about social responsibility. We're hearing
connection direct to the consumer. No one on the market
about companies treating their employees with respect,
is doing that now; everyone is focused on compliance
and about respect for the environment. I like that! A lot of
and brand protection. We have a clear vision to create
this is based simply on trust: building trust is something no
added value for our clients. You can't really do supply
one can be against.
chain optimization if your network is only part of the
Our approach carries over to other actions where we
supply chain, and we think serialization is the key to allow
have
taken a leadership role. Optel was instrumental in
optimization of all process both inside and outside of
starting
the Open SCS Consortium, which is something
manufacturing. We're the only vendor doing that.
that will benefit everyone involved in pharma supply
Does the same logic apply to the acquisition of
chain traceability [Ed. note: Open SCS is an effort of
Geotraceability, which tracks raw materials like food
leading vendors to agree on standards for various types
and natural resources from their source?
of traceability communications and connectivity, thus
Geotraceability currently operates in agriculture
reducing the amount of customization that traceability
and food, and so for us this represents a new market
implementations require.]
opportunity. I have structured Optel internally so that
Socially responsible business practices are critical to
there are dedicated pharma teams and food teams, so
our future.

06.2018 / Visit our website at www.PharmaceuticalCommerce.com / 15


http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - June 2018

Table of Contents
Pharmaceutical Commerce - June 2018 - Cover1
Pharmaceutical Commerce - June 2018 - Cover2
Pharmaceutical Commerce - June 2018 - Table of Contents
Pharmaceutical Commerce - June 2018 - 4
Pharmaceutical Commerce - June 2018 - 5
Pharmaceutical Commerce - June 2018 - 6
Pharmaceutical Commerce - June 2018 - 7
Pharmaceutical Commerce - June 2018 - 8
Pharmaceutical Commerce - June 2018 - 9
Pharmaceutical Commerce - June 2018 - 10
Pharmaceutical Commerce - June 2018 - 11
Pharmaceutical Commerce - June 2018 - 12
Pharmaceutical Commerce - June 2018 - 13
Pharmaceutical Commerce - June 2018 - 14
Pharmaceutical Commerce - June 2018 - 15
Pharmaceutical Commerce - June 2018 - 16
Pharmaceutical Commerce - June 2018 - 17
Pharmaceutical Commerce - June 2018 - 18
Pharmaceutical Commerce - June 2018 - 19
Pharmaceutical Commerce - June 2018 - 20
Pharmaceutical Commerce - June 2018 - 21
Pharmaceutical Commerce - June 2018 - 22
Pharmaceutical Commerce - June 2018 - 23
Pharmaceutical Commerce - June 2018 - 24
Pharmaceutical Commerce - June 2018 - 25
Pharmaceutical Commerce - June 2018 - 26
Pharmaceutical Commerce - June 2018 - 27
Pharmaceutical Commerce - June 2018 - 28
Pharmaceutical Commerce - June 2018 - 29
Pharmaceutical Commerce - June 2018 - 30
Pharmaceutical Commerce - June 2018 - 31
Pharmaceutical Commerce - June 2018 - 32
Pharmaceutical Commerce - June 2018 - 33
Pharmaceutical Commerce - June 2018 - 34
Pharmaceutical Commerce - June 2018 - Cover3
Pharmaceutical Commerce - June 2018 - Cover4
http://www.nxtbook.com/nxtbooks/pharmcomm/201909
http://www.nxtbook.com/nxtbooks/pharmcomm/201906
http://www.nxtbook.com/nxtbooks/pharmcomm/201903
http://www.nxtbook.com/nxtbooks/pharmcomm/201811
http://www.nxtbook.com/nxtbooks/pharmcomm/201809
http://www.nxtbook.com/nxtbooks/pharmcomm/201806
http://www.nxtbook.com/nxtbooks/pharmcomm/20180304
http://www.nxtbook.com/nxtbooks/pharmcomm/20171112
http://www.nxtbook.com/nxtbooks/pharmcomm/20170910
http://www.nxtbook.com/nxtbooks/pharmcomm/20170708
http://www.nxtbook.com/nxtbooks/pharmcomm/20170506
http://www.nxtbook.com/nxtbooks/pharmcomm/20170304
http://www.nxtbook.com/nxtbooks/pharmcomm/20170102
http://www.nxtbook.com/nxtbooks/pharmcomm/20161112
http://www.nxtbook.com/nxtbooks/pharmcomm/20160910
http://www.nxtbook.com/nxtbooks/pharmcomm/20160708
http://www.nxtbook.com/nxtbooks/pharmcomm/20160506
http://www.nxtbook.com/nxtbooks/pharmcomm/20160304
http://www.nxtbook.com/nxtbooks/pharmcomm/20160102
http://www.nxtbook.com/nxtbooks/pharmcomm/20151112
http://www.nxtbook.com/nxtbooks/pharmcomm/20150910
http://www.nxtbook.com/nxtbooks/pharmcomm/20150708
http://www.nxtbook.com/nxtbooks/pharmcomm/20150506
http://www.nxtbook.com/nxtbooks/pharmcomm/20150304
http://www.nxtbook.com/nxtbooks/pharmcomm/20150102
http://www.nxtbook.com/nxtbooks/pharmcomm/20141112
http://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
http://www.nxtbook.com/nxtbooks/pharmcomm/20140910
http://www.nxtbook.com/nxtbooks/pharmcomm/20140708
http://www.nxtbook.com/nxtbooks/pharmcomm/20140506
http://www.nxtbook.com/nxtbooks/pharmcomm/20140304
http://www.nxtbook.com/nxtbooks/pharmcomm/20140102
http://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
http://www.nxtbook.com/nxtbooks/pharmcomm/20131112
http://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
http://www.nxtbook.com/nxtbooks/pharmcomm/20130910
http://www.nxtbook.com/nxtbooks/pharmcomm/20130708
http://www.nxtbook.com/nxtbooks/pharmcomm/20130506
http://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
http://www.nxtbook.com/nxtbooks/pharmcomm/20130304
http://www.nxtbook.com/nxtbooks/pharmcomm/20130102
http://www.nxtbook.com/nxtbooks/pharmcomm/20121112
http://www.nxtbook.com/nxtbooks/pharmcomm/20120910
http://www.nxtbook.com/nxtbooks/pharmcomm/20120708
http://www.nxtbook.com/nxtbooks/pharmcomm/20120506
http://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
http://www.nxtbook.com/nxtbooks/pharmcomm/20120304
http://www.nxtbook.com/nxtbooks/pharmcomm/20120102
http://www.nxtbook.com/nxtbooks/pharmcomm/20111112
http://www.nxtbook.com/nxtbooks/pharmcomm/20110910
http://www.nxtbook.com/nxtbooks/pharmcomm/20110708
http://www.nxtbook.com/nxtbooks/pharmcomm/20110506
http://www.nxtbook.com/nxtbooks/pharmcomm/20110304
http://www.nxtbook.com/nxtbooks/pharmcomm/20110102
http://www.nxtbook.com/nxtbooks/pharmcomm/20101112
http://www.nxtbook.com/nxtbooks/pharmcomm/20100910
http://www.nxtbook.com/nxtbooks/pharmcomm/20100708
http://www.nxtbook.com/nxtbooks/pharmcomm/20100506
http://www.nxtbook.com/nxtbooks/pharmcomm/201004
http://www.nxtbook.com/nxtbooks/pharmcomm/201003
http://www.nxtbook.com/nxtbooks/pharmcomm/20100102
http://www.nxtbook.com/nxtbooks/pharmcomm/20091112
http://www.nxtbookMEDIA.com